TNF and rheumatoid arthritis: Despite advances in disease-modifying antirheumatic drugs and biologics, such as tumor necrosis factor (TNF) and Janus kinase (JAK) inhibitors, many patients with RA exhibit inadequate responses or develop resistance over time [3].